effective weight loss drugs
Why 7 Prescription Weight Loss Myths Undermine Results
Prescription weight-loss myths undermine results because they create unrealistic expectations, discourage adherence, and hide safety considerations, preventing patients from fully benefiting from GLP-1 therapies. A 2024 head-to-head trial showed tirzepatide achieved an average 22% total body weight reduction, outpacing semaglutide’s 15% loss. This statistic sets a new efficacy benchmark